This communication does not constitute an offer or invitation to
subscribe for or purchase any securities of Santhera Pharmaceuticals
Holding AG. This publication may contain certain forward-looking
statements concerning the Company and its business. Such statements
involve certain risks, uncertainties and other factors which could cause
the actual results, financial condition, performance or achievements of
the Company to be materially different from those expressed or implied
by such statements. Readers should therefore not place undue reliance on
these statements, particularly not in connection with any contract or
investment decision. The Company disclaims any obligation to update
these forward-looking statements.
# # #
Attachment
-- 2021 03 03_Vamorolone-LPLV_e_final
https://ml-eu.globenewswire.com/Resource/Download/4f1d6fad-83dd-4ee5-9d79-841e7821da9e
(END) Dow Jones Newswires
March 03, 2021 01:00 ET (06:00 GMT)